Global Gastrointestinal Stromal Tumor (GIST) Drug Market has been getting lots of traction from different emerging countries and regions and in the times of COVID-19, the market is expected to change % in terms of year on year growth. To study the impact of COVID-19, the research has been segmented by Type, By Application, By Regions and By Companies. The report will shed light on very important growth aspect of Gastrointestinal Stromal Tumor (GIST) Drug and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis By Type Segment:
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Price (If Available)
Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis By Application Segment:
Clinic
Hospital
Others
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis By Regions (Countries):-
The Gastrointestinal Stromal Tumor (GIST) Drug Market has been thoroughly researched with help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the regions i.e. North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Gastrointestinal Stromal Tumor (GIST) Drug Report:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Key data provided:
Market Size By Regions and Countries
Market Share By Regions and Countries
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Gastrointestinal Stromal Tumor (GIST) Drug Market:
Gastrointestinal Stromal Tumor (GIST) Drug market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The major vendors covered:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
The study objectives are:
To analyze and research the Gastrointestinal Stromal Tumor (GIST) Drug Market status and future forecast in North America, Europe, APAC and MEA involving value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Gastrointestinal Stromal Tumor (GIST) Drug Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Available Customizations in The Report:
We can add additional companies as per your choice in the report
We can add specific country/countries of your choice
We can add additional segments such as market by technology, raw material, distribution channel, platform etc.*
Investment Analysis in specific country
We can source details of suppliers and distributors for potential collaboration
* Data is subject to availability
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type (2020-2027)
1.3.2 Amcasertib
1.3.3 Anagrelide hydrochloride CR
1.3.4 APG-1351
1.3.5 Binimetinib
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2020-2027)
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2016-2027
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2016-2027
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Growth Rate by Regions
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Regions 2016-2020
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers
3.1.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers 2016-2020
3.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2016-2020)
3.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Ratio (CR5 and HHI)
3.3 Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturers
3.4 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
3.6 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Amcasertib Sales and Revenue (2016-2020)
4.1.2 Anagrelide hydrochloride CR Sales and Revenue (2016-2020)
4.1.3 APG-1351 Sales and Revenue (2016-2020)
4.1.4 Binimetinib Sales and Revenue (2016-2020)
4.1.5 Others Sales and Revenue (2016-2020)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type
4.4 Gastrointestinal Stromal Tumor (GIST) Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
6 United States
6.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
6.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Type
6.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Application
7 European Union
7.1 European Union Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
7.2 European Union Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Type
7.3 European Union Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Application
8 China
8.1 China Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
8.2 China Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Type
8.3 China Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
9.2 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Type
9.3 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Application
9.4 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Countries
9.4.1 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries
9.4.2 Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Ariad Pharmaceuticals, Inc.
10.1.1 Ariad Pharmaceuticals, Inc. Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.1.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.1.5 Ariad Pharmaceuticals, Inc. Recent Development
10.2 Arog Pharmaceuticals, Inc.
10.2.1 Arog Pharmaceuticals, Inc. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.2.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.2.5 Arog Pharmaceuticals, Inc. Recent Development
10.3 Array BioPharma Inc.
10.3.1 Array BioPharma Inc. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.3.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.3.5 Array BioPharma Inc. Recent Development
10.4 Astex Pharmaceuticals, Inc.
10.4.1 Astex Pharmaceuticals, Inc. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.4.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.4.5 Astex Pharmaceuticals, Inc. Recent Development
10.5 Blueprint Medicines Corporation
10.5.1 Blueprint Medicines Corporation Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.5.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.5.5 Blueprint Medicines Corporation Recent Development
10.6 Boston Biomedical, Inc.
10.6.1 Boston Biomedical, Inc. Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.6.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.6.5 Boston Biomedical, Inc. Recent Development
10.7 Calithera Biosciences, Inc.
10.7.1 Calithera Biosciences, Inc. Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.7.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.7.5 Calithera Biosciences, Inc. Recent Development
10.8 Chipscreen Biosciences Ltd
10.8.1 Chipscreen Biosciences Ltd Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.8.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.8.5 Chipscreen Biosciences Ltd Recent Development
10.9 Deciphera Pharmaceuticals, LLC
10.9.1 Deciphera Pharmaceuticals, LLC Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.9.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.9.5 Deciphera Pharmaceuticals, LLC Recent Development
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 F. Hoffmann-La Roche Ltd. Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Gastrointestinal Stromal Tumor (GIST) Drug
10.10.4 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
10.10.5 F. Hoffmann-La Roche Ltd. Recent Development
10.11 Horizon Pharma Plc
10.12 Immunicum AB
10.13 Jiangsu Hengrui Medicine Co., Ltd.
10.14 Kolltan Pharmaceuticals, Inc.
10.15 Natco Pharma Limited
10.16 Nerviano Medical Sciences S.r.l.
10.17 Novartis AG
10.18 Omeros Corporation
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
11.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
12 Market Forecast
12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue Forecast 2020-2027
12.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type
12.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application
12.4 Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Regions
12.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions 2020-2027
12.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Regions 2020-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
Table Gastrointestinal Stromal Tumor (GIST) Drug Key Market Segments
Table Major Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Covered in This Report
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type 2020-2027(K Pcs) & (Million US$)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Shar by Type 2016-2027
Figure Amcasertib Figures
Table Major Manufacturers of Amcasertib
Figure Anagrelide hydrochloride CR Figures
Table Major Manufacturers of Anagrelide hydrochloride CR
Figure APG-1351 Figures
Table Major Manufacturers of APG-1351
Figure Binimetinib Figures
Table Major Manufacturers of Binimetinib
Figure Others Figures
Table Major Manufacturers of Others
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application 2020-2027(K Pcs)
Figure Clinic Use Case
Figure Hospital Use Case
Figure Others Use Case
Figure Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size 2016-2027 (Million US$)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2016-2020 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Regions 2016-2020 (K Pcs) & (Million US$)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Regions 2016-2020 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions 2016-2020
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions 2016-2020
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions in 2020
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions 2016-2020 (Million US$)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions 2016-2020
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions 2016-2020
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (2016-2020) (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers (2016-2020)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2020
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2016-2020) (Million USD)
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2016-2020)
Figure Gastrointestinal Stromal Tumor (GIST) Drug Value Share by Manufacturers in 2020
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Price (2016-2020) (USD/Pcs)
Table Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Plants/Factories Distribution
Table Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Area Served
Table Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
Table Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Amcasertib Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Anagrelide hydrochloride CR Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global APG-1351 Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Binimetinib Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Others Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2020) (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2016-2020)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2020)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2016-2020) (Million US$)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2016-2020)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2016-2020)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type in 2020
Table Gastrointestinal Stromal Tumor (GIST) Drug Price by Type 2016-2020 (USD/Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2020) (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2016-2020)
Figure Global Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2016-2020)
Figure Global Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2016-2020)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2016-2020 (K Pcs)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2016-2020 (Million US$)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2020) (K Pcs)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2020)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company in 2020
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2020) (K Pcs)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2020)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2020
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2020) (K Pcs)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2020)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2020
Figure European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2016-2020 (K Pcs)
Figure European Union Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2020) (K Pcs)
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2020)
Figure European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company in 2020
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2020) (K Pcs)
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2020)
Figure 2020 European Union Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2020) (K Pcs)
Table European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2020)
Figure 2020 European Union Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2016-2020 (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2016-2020 (Million US$)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2020) (K Pcs)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2020)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company in 2020
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2020) (K Pcs)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2020)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2020
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2020) (K Pcs)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2020)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2020
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2016-2020 (K Pcs)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2020) (K Pcs)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2020)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company in 2020
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2020) (K Pcs)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2020)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2020
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2020) (K Pcs)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2020)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2020
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales by Countries (2016-2020) (K Pcs)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2016-2020)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2020
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2016-2020)
Figure Rest of World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2020
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020) (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2020) (K Pcs)
Figure Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020) (K Pcs)
Figure Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2020) (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020) (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2020) (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020) (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate (2016-2020) (K Pcs)
Table Ariad Pharmaceuticals, Inc. Company Details
Table Ariad Pharmaceuticals, Inc. Description and Business Overview
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Ariad Pharmaceuticals, Inc. Recent Development
Table Arog Pharmaceuticals, Inc. Company Details
Table Arog Pharmaceuticals, Inc. Description and Business Overview
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Arog Pharmaceuticals, Inc. Recent Development
Table Array BioPharma Inc. Company Details
Table Array BioPharma Inc. Description and Business Overview
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Array BioPharma Inc. Recent Development
Table Astex Pharmaceuticals, Inc. Company Details
Table Astex Pharmaceuticals, Inc. Description and Business Overview
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Astex Pharmaceuticals, Inc. Recent Development
Table Blueprint Medicines Corporation Company Details
Table Blueprint Medicines Corporation Description and Business Overview
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Blueprint Medicines Corporation Recent Development
Table Boston Biomedical, Inc. Company Details
Table Boston Biomedical, Inc. Description and Business Overview
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Boston Biomedical, Inc. Recent Development
Table Calithera Biosciences, Inc. Company Details
Table Calithera Biosciences, Inc. Description and Business Overview
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Calithera Biosciences, Inc. Recent Development
Table Chipscreen Biosciences Ltd Company Details
Table Chipscreen Biosciences Ltd Description and Business Overview
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Chipscreen Biosciences Ltd Recent Development
Table Deciphera Pharmaceuticals, LLC Company Details
Table Deciphera Pharmaceuticals, LLC Description and Business Overview
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table Deciphera Pharmaceuticals, LLC Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Description and Business Overview
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2020)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Horizon Pharma Plc Company Details
Table Immunicum AB Company Details
Table Jiangsu Hengrui Medicine Co., Ltd. Company Details
Table Kolltan Pharmaceuticals, Inc. Company Details
Table Natco Pharma Limited Company Details
Table Nerviano Medical Sciences S.r.l. Company Details
Table Novartis AG Company Details
Table Omeros Corporation Company Details
Figure Gastrointestinal Stromal Tumor (GIST) Drug Value Chain
Table Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs) & (Million US$)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type 2020-2025
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application 2020-2025
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Regions 2020-2025
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Regions 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Regions 2020-2027(K Pcs)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Regions 2020-2025
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure European Union Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure European Union Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast 2020-2027(K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast 2020-2027(Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources